Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 4826 of 5804
-
Can an iPad avatar help you quit smoking?
Disease control CompletedThe investigators have developed a hybrid computer- and person-delivered intervention, called "C-Raven" for smoking cessation that is tailored to people with tobacco use in Baltimore City. The computer delivered component consists of two \~20 minute sessions on an iPad guided by …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New antibody drug tested in patients with Hard-to-Treat cancers
Disease control Completedthe main purpose: * Evaluate the safety and resistance of BAT6026 injection as a single agent in the treatment of patients with locally advanced or metastatic solid tumors Acceptability * Explore maximum tolerated dose (MTD) or maximum administered dose (MAD) and be phase II or …
Phase: PHASE1 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Minnesota program aims to keep injured workers employed
Knowledge-focused CompletedMN RETAIN Phase 2 Sub-study is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored joi…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New study tracks brain function after radiation for head and neck cancer
Knowledge-focused Recruiting nowThe researchers are doing this study to collect more information about if, and how, neurocognitive function may be affected in people being treated with radiation therapy for head and neck cancer. Part of this study is to see if patients diagnosed with head and neck cancer who ar…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
COVID drug trial for kids halted early
Disease control TerminatedThe purpose for this study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID -19) and to confirm the dose.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Experimental drug iptacopan tested for rare blood disorders
Disease control TerminatedThe main purpose of this study was to evaluate the efficacy and safety of iptacopan in participants with autoimmune benign hematological disorders such as primary immune thrombocytopenia and primary cold agglutinin disease.
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Scientists dive deep into immune system to unlock HPV vaccine secrets
Knowledge-focused OngoingThis is a single center, longitudinal cohort study in which subjects will receive 9-valent HPV vaccine according to package insert (i.e., one dose of 9-valent HPV vaccine on day (D) 0 followed by a second dose 2 months later and a third dose 6 months later). Immune responses in …
Phase: PHASE4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Scientists collect heart biopsies to decode heart disease mysteries
Knowledge-focused Recruiting nowUse samples procured from patients to improve understanding of molecular, cellular, and tissue-level processes produced by a variety of cardiac diseases and therapeutic interventions.
Sponsor: Kenneth S. Campbell • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Phone app eases pandemic stress in minority communities
Symptom relief CompletedThe proposed research focuses on evaluating the mobile application, Easing Anxiety Sensitivity for Everyone (EASE), to improve overall public health that concerns risks and mental health status during the coronavirus disease of 2019 (COVID-19) pandemic and to minimize the existin…
Phase: NA • Sponsor: University of Houston • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Could a single CF gene copy change your infection risk?
Knowledge-focused Recruiting nowA research team member will brush the inferior surface of the subjects' middle turbinate (nasal cavity) using a cytology brush to obtain the cells needed to perform our functional respiratory assays. An individual trained in phlebotomy will draw one 3 ml lavender top tube of blo…
Sponsor: Philip Polgreen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Could ditching Beta-Blockers improve heart function?
Knowledge-focused Recruiting nowThis is a prospective pilot study to evaluate changes before and 4 weeks after beta-blocker withdrawal in 30 HFpEF patients.
Phase: NA • Sponsor: UConn Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
CF gene carriers may face hidden organ risks
Knowledge-focused Recruiting nowThe overarching hypothesis is that CF carriers are at increased risk for developing most of the extrapulmonary conditions associated with CF compared to the general population. Specifically, it is hypothesized that this pilot data will detect subclinical evidence of pancreatic an…
Sponsor: Philip Polgreen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Scientists hunt for clues to predict liver cancer drug response
Knowledge-focused CompletedHepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths worldwide, and HCC is more frequently observed in Asia, including South Korea. As HCC is often accompanied by chronic hepatitis B or C virus and liver cirrhosis, treatment of HCC consider not o…
Sponsor: CHA University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:13 UTC
-
French hospital pilots early discharge for new moms with home midwife support
Knowledge-focused CompletedIn 2016, according to the national perinatal survey, the average length of stay in maternity hospitals in France after a vaginal delivery was 4.0 days, confirming the decrease in this length of stay compared with previous surveys, but placing France among the Western countries wi…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Light weights, big gains: study shows lifting to failure works wonders
Knowledge-focused CompletedThe goal of this clinical trial is to learn whether low-load resistance training performed to muscle failure can produce similar increases in muscle size and strength as high-load resistance training in healthy untrained young adult males. The main questions it aims to answer ar…
Phase: NA • Sponsor: Akdeniz University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New combo pill may lower cholesterol better than statins alone
Disease control CompletedA Multi-center, Open-label, Observational Study to evaluate the Efficacy and Safety of Pitavastatin/Ezetimibe after switching from Statin Monotherapy to Pitavastatin/Ezetimibe in patients with Hypercholesterolemia
Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New registry aims to uncover how cancer ages young bodies
Knowledge-focused Recruiting nowPurpose: This study aims to create a registry of childhood, adolescent, and young adult patients with cancer (\<40 years-old at cancer diagnosis), entitled the 'UNC Childhood, Adolescent, and Young Adult Cancer Cohort' (UNC-CAYACC). This resource will serve to support cancer outc…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Experimental cancer drug WBC100 tested in early trial – but study halted
Disease control TerminatedThis is a phase I clinical study of WBC100 in patients with advanced solid tumor.
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
LUTATHERA safety checked in 347 patients after market approval
Knowledge-focused CompletedThis study was a multicenter observational study with a central registration system and all-case surveillance system without a control group.
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Peer support after prison may boost hepatitis c care
Disease control OngoingThe overarching goal of this study is to develop a peer-based care coordination intervention for individuals with Hepatitis C Virus (HCV) who were recently released from correctional settings to promote linkage to and retention in HCV care. The investigators will assess the exist…
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC